Dermesse sunscreen spf30 lotion

Active ingredients

Octinoxiate 7% w/w

Titanium Dioxide 2% w/w

Purpose

Sunscreen

Uses:

Helps prevent sunburn

Warnings:

For external use only

Do not use on damaged or broken skin.

When using this product:

Keep out of eyes. Rinse with water to remove.

Stop use and ask doctor if

Rash or irritation develops

Keep out of reach of children

If swallowed, get medical help or contact a Poison Control Center right away.

Warnings section

Skin Cancer/Skin Aging Alert:Spending time in the sun increases your risk of skin cancer and early skin aging. This product has been shown only to prevent sunburn, not skin cancer or early skin aging.

Directions

Apply liberally 15 minutes before sun exposure

Reapply

After 40 minutes of swimming or sweating

Immediately after towel drying

At least every 2 hours

Otc - ask doctor section

Children under 6 months:Ask a doctor

Inactive ingredients

Water, Aloe Barbadensis Leaf Extract, Isocetyl Stearate, Sorbitol, Cetearyl Alcohol, Ceteareth-20, Tocopheryl Acetate, Acetyl Hexapdptide-8, Hydrolyzed Rice Protein, Alcohol SDA-40, Dimethicone, Octyl Salicylate, Cety Alcohol, Methicone, Sodium Laureth Sulfate, Carbomer, Green Tea (Carnellia Sinensis) Leaf Extract, Fragrance, Triethanolamine, Stearic Acid, Lecithin, Alumina, Caprylyl Glycol, Methylisothiazolinone

Other information

Protect this product from excessive heat and direct sun.

Questions or comments?

866-494-4466 or visit www.dermesse.com

Ingredients and appearance - Product information

Dermesse sunscreen spf30 lotion- Octinoxate, titanium dioxide

Product information

Product Type HUMAN OTC DRUG LABEL Item Code (Source) NDC: 68723-330
Route of Administration Topical

Active Ingredient/Active Moiety

Ingredient Name Strength
Octinoxate ( UNII: 4Y5P7MUD51)( Octinoxate - UNII: 4Y5P7MUD51 ) 70 mgin 1 g
Titanium dioxide ( UNII: 15FIX9V2JP)( Titanium dioxide - UNII: 15FIX9V2JP ) 20 mgin 1 g

Inactive Ingredients

Ingredient Name Code
Water ( UNII: 059QF0KO0R)
Isocetyl stearate ( UNII: 3RJ7186O9W)
Sorbitol ( UNII: 506T60A25R)
Cetostearyl alcohol ( UNII: 2DMT128M1S)
Polyoxyl 20 cetostearyl ether ( UNII: YRC528SWUY)
.alpha.-tocopherol acetate ( UNII: 9E8X80D2L0)
Acetyl hexapeptide-8 ( UNII: L4EL31FWIL)
Alcohol ( UNII: 3K9958V90M)
Dimethicone 350 ( UNII: 2Y53S6ATLU)
Octisalate ( UNII: 4X49Y0596W)
Cetyl alcohol ( UNII: 936JST6JCN)
Methicone (20 cst) ( UNII: 6777U11MKT)
Sodium laureth sulfate ( UNII: BPV390UAP0)
Carbomer interpolymer type a (allyl sucrose crosslinked) ( UNII: 59TL3WG5CO)
Green tea leaf ( UNII: W2ZU1RY8B0)
Trolamine ( UNII: 9O3K93S3TK)
Stearic acid ( UNII: 4ELV7Z65AP)
Lecithin, soybean ( UNII: 1DI56QDM62)
Aluminum oxide ( UNII: LMI26O6933)
Caprylyl glycol ( UNII: 00YIU5438U)
Methylisothiazolinone ( UNII: 229D0E1QFA)

Product Characteristics

Packaging

# Item Code Package Description Marketing Start Date
1 NDC: 68723-330-02 57g in 1 BOTTLE 2012/04/01

Marketing Information

Marketing Category Application Number or Monograph Citation Territorial Authority Marketing Start Date
OTC monograph final part352 USA 2012/04/01

Labeler - Axia Medical Solutions, LLC( 929224694)

Package label.principal display panel